We have studied the mechanisms underlying expansion of recombinant interleukin-2 (rlL-2)-stimulated natural killer (NK) cells in vitro. A population of NK cells expressing the CD56+/CD3-phenotype (98.9% 2 0.42%) was obtained from normal human peripheral blood mononuclear cells (PBMNC) by fluorescence-activated cell sorting (FACS). Culture of NK cells in media containing rlL-2 (1,000 U/mL) for 18 days resulted in a population of activated NK cells (ANK) with significantly enhanced cytotoxicity, but only 2.6 k 0.56-fold expansion of cell number compared with the starting NK population. Culture of starting NK populations and autologous PBMNC in a Transwell system (Costar, Cambridge, MA), providing separation of the two cell populations by a 0.4-pm pore membrane, resulted in a dose-dependent increase in fold expansion of ANK (expansion = 19.9 f 4.0-fold; P c .OOl; n = 22) significantly greater than that observed when NK were cultured alone. Further experiments using the Transwell system showed that the stimulatory effect of autologous PBMNC on ANK progenitor proliferation resides in the CD14+ monocytefraction (maximal expansion = 14.5 f 1.5-fold; n = 17) and not in the CD5+ T-lymphocyte or CD19+ B-lymphocyte fractions. Direct coculture of purified NK and EVERAL recombinant interleukin-2 (rIL-2)-activated S killer cell populations have activity in humans and animals against various fresh and cultured tumor targets both in vitro and in
We have studied the mechanisms underlying expansion of recombinant interleukin-2 (rlL-2)-stimulated natural killer (NK) cells in vitro. A population of NK cells expressing the CD56+/CD3-phenotype (98.9% 2 0.42%) was obtained from normal human peripheral blood mononuclear cells (PBMNC) by fluorescence-activated cell sorting (FACS). Culture of NK cells in media containing rlL-2 (1,000 U/mL) for 18 days resulted in a population of activated NK cells (ANK) with significantly enhanced cytotoxicity, but only 2.6 k 0.56-fold expansion of cell number compared with the starting NK population. Culture of starting NK populations and autologous PBMNC in a Transwell system (Costar, Cambridge, MA), providing separation of the two cell populations by a 0.4-pm pore membrane, resulted in a dose-dependent increase in fold expansion of ANK (expansion = 19.9 f 4.0-fold; P c .OOl; n = 22) significantly greater than that observed when NK were cultured alone. Further experiments using the Transwell system showed that the stimulatory effect of autologous PBMNC on ANK progenitor proliferation resides in the CD14+ monocytefraction (maximal expansion = 14.5 f 1.5-fold; n = 17) and not in the CD5+ T-lymphocyte or CD19+ B-lymphocyte fractions. Direct coculture of purified NK and EVERAL recombinant interleukin-2 (rIL-2)-activated
S killer cell populations have activity in humans and animals against various fresh and cultured tumor targets both in vitro and in
The lytic activity of these populations is predominantly derived from activated natural killer (NK) cells that are more potent than other heterogeneous killer cell population^.^,^ Selective depletion of murine NK cells in vivo abolishes the antitumor effect against subsequently inoculated tumor, supporting a role for NK cells in immune surveillance? We and others have previously shown that it is possible to obtain a population of relatively pure activated NK termed "adherent lymphokineactivated killer cells" (A-LAK), which are selected by their propensity to adhere to plastic in the presence of rIL-2.10-15 These cells express high levels of the CD56 surface antigen associated with rIL-2-activated NK cells, but do not express the a/P T-cell receptor (CD3). A-LAK have greater in vitro cytotoxicity than conventional LAK on a per-cell basis,15 may have more antitumor efficacy when infused in vivo, and may require lower cell doses and lower rIL-2 doses than LAK cells to achieve their antitumor effect.
It is unclear why A-LAK expand in vitro while fluorescence-activated cell sorting (FACS) of CD56+(dim)/ CD16+(bri&t) NK in other systems expand poorly with rIL-2 alone. 16 We hypothesized that autologous accessory cell populations present in peripheral blood mononuclear cells (PBMNC) are important for the expansion of rIL-2-activated NK. In the present study we generate a population of activated NK cells (ANK) that can be obtained directly by selection of CD56+/CD3-cells from the peripheral blood and examine the role of accessory cell populations on proliferation of ANK.
MATERIALS AND METHODS
Patient population. Twenty-eight healthy adult volunteers, ages 21 to 43 years, were studied. Peripheral blood was collected in autologous monocytes in the same compartment, thus permitting cell-cell contact, resulted in significantly greater expansion of the ANK population (30.6 f 4.7-fold expansion, P e .001; n = 10) than that observed when NK and monocytes were separated by the Transwell membrane. Finally, depletion of PBMNC of cells bearing CD5 and CD8 by panning on antibody-coated plastic flasks resulted in a starting cell population enriched for NK progenitors and for monocytes. Cultures of this resultant population for 18 days in the presence of rlL-2 yielded an ANK population similar t o that obtained when CD56+/CD3-cells obtained by FACS were cocultured with autologous monocytes. These results suggest that proliferation of ANK requires autologous monocytes and is in part mediated by humoral factors, but is enhanced when NK and monocytes are in direct cell-cell contact. Depletion of cells bearing CD5 and CD8 from PBMNC is a single efficient method for obtaining a starting population capable of producing large numbers of ANK in culture that may lead t o new therapeutic uses for the ANK population.
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syringes containing preservative-free heparin. All samples were obtained using guidelines approved by the Committee on the Use of Human Subjects in Research at the University of Minnesota.
PBMNC obtained by FicollHypaque (specific gravity 1.077) (Sigma Diagnostics, St Louis, MO) density gradient centrifugation (30 minutes at 37°C and 40Og) were used as a source of accessory cells and for NK cells. All accessory cell populations were labeled with monoclonal antibodies (MoAbs) (Becton Dickinson, Mountain View, CA) as indicated. Cells were sorted on a FACS-Star laser flow cytometry system equipped with a consort 40 computer (Becton Dickinson) by their high-density fluorescence compared with isotype-matched fluorescent-conjugated control antibody. All sorted accessory cell populations were found to be greater than 98% pure on re-analysis. NK cells were obtained by an initial negative depletion of T lymphocytes and monocytes followed by FACS.
were then incubated with goat antimouse IgG coated immunomagnetic beads (30 beaddcell) (Advanced Magnetics Inc, Cambridge, MA) and 5% fetal calf serum (Hyclone Laboratories, Logan, UT) for 30 minutes at 4°C with gentle agitation every 5 minutes. The depleted population was obtained by removing rosetted cells after exposure to a strong magnetic field. Although no specific antibodies against monocytes were added, greater than 90% of monocytes were depleted during this step by nonspecific phagocytosis of immunomagnetic particles. The resultant bead depleted population contained 11.3% f 0.7% of the starting population and showed a significant enrichment of CD56+/CD3-NK cells (44% f 5%). Because the bead-depleted population contained a residual population of 12% f 1.9% T lymphocytes, remaining cells were labeled with 250 ng/ lo6 cells fluorescein isothiocyanate (FITC) conjugated anti-CD3 and phycoerythrin (PE) conjugated anti-CD56 for sorting. NK cells were sorted using the following gates: first, to insure exclusion of all T lymphocytes, the FITC CD3 gate was chosen below the FITC IgGl control antibody. Sorting windows were then defined relative to control antibodies that separated the bead depleted population into a sort positive window CD56+/CD3-. The resultant sort positive window included mainly CD56+dim cells and a minor population of CD56+bri@ cells. CD56+ NK cell subsets were sorted using similar criteria with the indicated antibodies.
T lymphocytes were obtained by direct sorting of PBMNC labeled with 125 ng/106 cells FITCconjugated anti-CD5. CD5 was used for this selection to avoid the high mitogenic stimulation observed with CD3 antibodies. Double staining with anti-CD3 and anti-CD5 demonstrated that in PBMNC over 90% of T lymphocytes coexpressed both antigens.
PBMNC were first enriched for monocytes and B lymphocytes by depletion of T lymphocytes with 2-amino ethylisothiouronium bromide (AET)-treated sheep red blood cells (RBCs) (Kroy Medical Inc, Stillwater, MN). Briefly, PBMNC were incubated with a 5% (vol/vol) suspension of AET-treated sheep RBCs for 10 minutes at 37T, soft pelleted by centrifugation (5 minutes at 37"C), then further incubated at 4°C for 1 hour. Nonrosetted cells were separated by a second Ficoll-Hypaque density centrifugation at 4°C. This enriched population, comprised of 46.7% f 3.4% CD14+ monocytes and 16.4% f 2.6% CD19+ B lymphocytes, was then labeled with 125 ng/106 cells PE-conjugated CD14 and FITC-conjugated CD19. Monocytes and B lymphocytes were then purified by FACS.
An NK-and monocyte-enriched population was prepared by panning PBMNC onto MicroCELLector flasks coated with CD5 and CD8 antibodies (generously provided by Applied Immune Sciences, Inc, Menlo Park, CA). These devices are primed with calcium/magnesium-free phosphatebuffered saline (PBS-CMF) containing 1 mmol/L EDTA. The devices were then inoculated with 20 x lo6 PBMNC suspended in 4 mL of PBS-CMF supplemented with 1 mmol/L EDTA and 0.5% Ig (Gamimune N; Miles Inc, Elkhart, IN). After a 1-hour incubation on a flat, level, nonvibrating surface at room temperature, nonadherent cells were removed by gentle agitation followed by a single wash. The resultant nonadherent cells were reinoculated into a fresh MicroCELLector flask for a second depletion before use.
Sorted or enriched NK populations were cultured in 24-well plates equipped with a Transwell insert (Costar, Cambridge, MA). The Transwell insert consisted of a 200-kL upper well separated from an 800-pL bottom well by a 0.4-bm microporous polycarbonate membrane that had not been pretreated in tissue culture media. The distance between the Transwell membrane and the well bottom was 1 mm. All cells were resuspended in complete culture media consisting of RPMI 1640 supplemented with 0, 1, 10, 100, or 1,000 U/mL rIL-2 as indicated Purijicarion of T lymphocytes.
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(a generous gift from Hoffmann-La Roche, Nutley, NJ), 10% human heat-inactivated AB serum (North American Biologicals, Miami, FL), 2 mmol/L L-glutamine (GIBCO Laboratories, Grand Island, NY), and penicillin (1,000 U/mL) plus streptomycin (100 U/mL) (GIBCO). Sorted NK populations were plated in the bottom well of the Transwell system at a concentration of 1 x 105 CD56+/CD3-cells/mL or 5 x lo5 CDS/CD8-depleted cells/mL. The top well insert was inoculated with complete culture media alone or accessory cell populations as indicated. Culture plates were incubated in a humidified atmosphere, 5% COz and at 37°C. After 4 to 5 days of incubation, each well was fed with fresh rIL-2. At day 7, the Transwell insert was removed and discarded, and the culture volume was doubled by adding fresh complete culture media. On days 11 and 14, the 24-well plate was centrifuged at 500 rpm for 5 minutes and media were carefully removed and replaced with 2 mL of fresh complete media containing fresh rIL-2. The media volume was expanded as needed to maintain a cell concentration of less than 2 x lo6 cells/mL. On day 18 the cultures were terminated and cells were analyzed for expansion, cytotoxicity, and phenotype characteristics. All cell populations were counted in a hemocytometer to determine fold expansion. Results of experimental points obtained from multiple experiments were reported as mean 21 standard error of the mean (SEM). Significance levels were determined by two-sided Student's t-test analysis.
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RESULTS
NK cells
were enriched from P B M N C by immunomagnetic bead depletion of T lymphocytes using an anti-CD3 MoAb. Culture of the starting NK population in complete culture media alone containing 1,000 U/mL rIL-2 resulted in minimal expansion of ANK (2.6 2 0.56-fold, n = 22). We then cultured sorted NK cells in a Transwell system allowing free passage of soluble factors but prohibiting direct cell contact of NK and cocultured accessory cell populations. Culture of selected CD56+ / CD3-NK in the bottom well and autologous PBMNC in the top well resulted in an accessory cell dose-dependent increase in expansion of ANK compared with rIL-2 containing media alone (Fig 1) . Zero to 1 U/mL rIL-2 did not stimulate NK proliferation. However, doses ranging between 10 and 1,000 U/mL equally stimulated NK proliferation (Fig 2) .
To determine if the proliferation of NK could be attributed to expansion of a small subset of starting NK cells, CD56+ NK cell subsets were sorted on the basis of their coexpression of CD2, CD8, or CD16. Incubation of NK with saturating concentrations of anti-CD7 show that virtually all CD56+ NK are CD7+. This antigen does not differentiate NK cell subsets. The NK subsets described above were cocultured with 1,000 U/mL rIL-2 and autologous PBMNC separated by a Transwell (n = 5). There were differences in proliferation observed between CD56+ NK subsets where under these conditions CD56+/CD2+, CD56+/CD8-, and CD56+ /CD16-NK expanded significantly better than CD56+/CD2-(P = .004), CD56+/CD8+ (P = .046), or CD56+/CD16+ (P = .029) cells, respectively (Fig 3) . The smallest CD56+/CD16-subset (5% to 10% of out the 18-day culture period as specified. There was no significant difference in proliferation between 10,100, or 1,000 U/mL of rlL-2.
the CD56+/CD3-population) had the highest proliferation (50.3 2 10-fold expansion, n = 5, P = .002), while CD56+/ CD16+ cells had similar proliferation (19.56 2 5.8, P = not significant) compared with the unseparated CD56+/CD3-starting NK population. We next determined which accessory cell population was responsible for the increase in ANK expansion. Addition of 0.5 to 1.0 x lo6 sorted CD5+ T lymphocytes or 0.25 to 0.5 x lo6 CD19+ sorted B lymphocytes to the top well of the Transwell did not change the expansion of ANK compared with rIL-2 containing media alone. In contrast, addition of CD14+ monocytes to the top well significantly increased expansion of ANK in a dose-dependent manner (maximal expansion = 14.1-C 1.5-fold at 5.0 x lo5 monocytes/mL; n = 17). This was not significantly different from the proliferation of ANK seen when 1 x lo6 PBMNC/mL were added to the Transwell (Fig 4) .
We next studied the effect of cell-cell interaction on with rlL-2 1,000 U/mL and were analyzed at day 18. There were significant differences in fold expansion observed between these CD56+ NK subsets (CD2-Y CD2+, P = .004; CD8-v CD8+, P = .046; CD16-vCD16+,P = .029).
For Further experiments were designed to determine if the maximal effect of monocytes on NK were dependent on direct cell-cell interactions or simply mediated through increased soluble factors when cell-cell contact is permitted. Addition of 1.0 x lo5 CD56+/CD3-NK to 5.0 x l o 5 CD14+ monocytes in the upper well of the Transwell had no effect on ANK expansion in the bottom well when compared with experiments in which CD14+ monocytes alone were added to the Transwell. However, direct cellcell contact of CD14+ monocytes and the starting NK always resulted in significantly greater proliferation of ANK than that seen when monocytes were separated from the starting NK population by a microporous membrane (Fig 5) .
Cell populations resulting from culture of sorted NK under the conditions described above were evaluated at termination of culture for surface expression of antigens associated with NK or other lymphoid cells. After the 18-day culture period, 96.4% & 0.7% of ANK derived from CD56+ /CD3-sorted cells remained CD56+ / CD3-, with a significant increase in the proportion of CD56+(bright)/CD3-compared with the starting sorted population (83.1% & 2.1% v 6.8% ? 1.2%, P < .001; n = 27).
ANK otherwise maintained their coexpression of CD2 and CD8 but decreased their expression of CD16 (67.7% 2 4.1% ~3 1 . 7 % ? 3.4%,P < .001,n = 10) andCD7(78% & 11.6% v 40.4% f 5.8%, P = .01) compared with the phenotype at culture initiation. Expression of other surface antigens evaluated on the NK starting population were not significantly changed on ANK by the rIL-2 culture (Table 1, Fig 6, A through H). Phenotypic characteristics of resultant ANK were similar under all culture conditions described above, irrespective of the presence or absence of accessory cell populations during the rIL-2 culture.
Culture of ANK for 18 days in the presence of rIL-2 resulted in significant increases in cytotoxicity compared with the unstimulated NK starting popula-
Phenotype of ANK.
Cytotoxicity ofANK. tion against K562 (effector to target ratio 2.21,69% 2 2.4% v 29% 2 3.6%, P < .001) and Raji (E:T2.2:1,49.0% c 3.1% v 1% 2 O S % , P < .OOl). In subsequent experiments described above, testing the effects of accessory cell populations on proliferation, similar results with cultured ANK against K562 and Raji were observed irrespective of the presence or absence of accessory cells or specific accessory cell subpopulations (Fig 7) . Cytotoxicity of ANK derived from specific CD56+ NK subsets (CD8+, CD8-, CD16+, CD16-) was not different from that obtained from ANK derived from unseparated CD56+ /CD3-sorted cells. Cells cultured with 1,000 U/mL of rIL-2 killed NK-resistant Raji targets significantly better than those cultured with 10 U/mL (E:T 2.2:1,49 2 3.1 v 22.8 c 7, P = .003, n = 4) but K562 killing was not significantly different.
OptimizingANK expansion by a negative depletion method. We next attempted to increase the yield of cultured ANK from starting NK populations. Our data with FACSpurified populations suggested that optimal expansion of ANK could be obtained by direct coculture of NK and monocytes in the presence of rIL-2. PBMNC were panned on CD5 and CD8 antibody-coated flasks, and the nonadherent depleted population was recovered (n = 11). The resultant population yielded 23.5% & 2.1% of the starting cells and was significantly depleted of CD3, CD5, and CD8 positive cells. Phenotype analysis of this depleted population showed that CD56+/CD3-NK were enriched to 15% 2 2.6%, monocytes were enriched to 48% 2 4.4%, and CD19+ B lymphocytes remained at 4.4% ? 0.7%, similar to unseparated PBMNC (Table 2 ). This CD5/CD8-depleted population was cultured under identical culture conditions as for Transwell experiments, except in standard 24-well plates. As predicted, there was marked expansion of ANK using this negatively depleted population, which was at least as good as expansion seen with positively selected NK cocultured together with 5.0 x lo5 CD14+ monocytes. Similar to Transwell cultures, there was minimal proliferation with 0 to 1 U/mL of rIL-2 and prolifera- tion was similar at rIL-2 concentrations of 10 to 1,000 U/mL (Fig SA) . Since staining characteristics of anti-CD56 probably underestimate the number of CD56+(d1m) NK progenitors in the CDS/CDS-depleted population, no direct comparison in fold expansion could be made with FACS-derived starting NK. However, the absolute number of cultured ANK derived from the CDS/CDS-depleted population was always at least several fold higher than parallel experiments initiated with 1 x lo5 sorted CD56+/ CD3-NK. After 18 days in culture, neither monocytes nor B lymphocytes comprised more than 1.2% of the final population, and 93.6% 2 2.6% of all cells were CD56+/CD3-, demonstrating that expansion in culture was from expansion of ANK (Table 2 and Fig 6, I through L) . Cytotoxicity assays with these cells showed potent activity against both K562 and Raji similar to that observed for ANK derived from sorted CD56+/CD3-NK (data not shown). Consistent with the Transwell experiments, CDS/CDS-depleted populations cultured with high concentrations of rIL-2 killed Raji targets significantly better than lower concentrations (Fig 8B) .
DISCUSSION
In this study we evaluate the role of autologous accessory cells on the proliferation and cytotoxicity of purified human NK cells. We show that FACS-purified NK expand minimally in serum containing media with high-dose rIL-2 alone. These data are similar to those of Nagler et al, who demonstrated similar results with sorted CD56+(d1m) NK16 that expressed only intermediate rIL-2 receptor^.'^ Yet, we demonstrate that when PBMNC accessory cells are cultured with various NK cell subsets and rIL-2 for 18 days, separated by a microporous membrane, a significant increase in activated NK cell proliferation is observed. This proliferative effect is dependent on accessory cell dose, rIL-2 concentration, and specific starting NK subset. In our system, proliferative effect is derived from the monocyte subpopulation of PBMNC, yet other populations with appropriate activation stimuli may serve similar functions.ls Because direct cell-cell contact is prohibited in Transwell cultures, the mechanism of this enhanced proliferation is believed to be at least in part mediated through soluble factors. Direct coculture of monocytes and NK with rIL-2, permitting cell-cell contact, markedly increased the number of ANK recovered compared with conditions in which monocytes were placed in a separate chamber. These data suggest that, in addition to monocyte-derived soluble factors, direct cell-cell contact provides an enhancing proliferative signal. It is unclear whether cell-cell contact mediates this effect by increased release of monocyte-derived factors induced by NK contact or by independent mechanisms. The similar results obtained from mixing studies with monocytes and NK compared with monocytes alone in the Transwell suggest that maximal ANK proliferation induced by monocytes is not mediated by soluble factors alone.
In our studies starting NK and monocyte populations were sorted by positive selection and during initiation of culture were coated with MoAbs CD56 and CD14, respectively. It is well described that both NK and monocytes express FcyRIII receptors (CD16). 19, 20 Recently it has been shown that FcyRIII on monocytes is a transmembrane glycoprotein with an antigenic and peptide core identical to that found on NK, both a product of the FcyRIII-2 gene.21 To determine the importance of a direct effect of CD56 and/or CD14 antibodies on the stimulation of the starting NK population or an indirect effect via FcyRIII, we developed a method for selection of the starting NK population not requiring these antibodies based on a panning technique previously described by others. 22 We performed a negative depletion with CD5-and CD8-coated flasks to enrich for monocytes and NK. Subsequent 18-day culture of the depleted population yielded similar ANK populations with identical phenotype, proliferation, rIL-2 responsiveness, and cytotoxic capacity. This excludes specific involvement of CD56 and CD14 antibodies as mediators of proliferation of CD56+ NK by CD14+ monocytes. Although FcyRIII on NK have been implicated in several activation mechanisms and cross-linking of FcyRIII on NK with FcR on targets have been shown to be important in this activation mechanism,l* the precise role of FcyRIII on NK and FcRI (CD64), FcRII (CD32), and FcyRIII (CD16) on monocytes will require further study in our system. When NK and monocytes were cocultured with highdose rIL-2, after 18 days there was less than 1% residual monocytes. The mechanism of monocyte loss in our culture ' " 1 EFFECTOR : TARGET RATIO system is unknown. It has been shown that activated NK can lyse infected monocytes or fresh monocytes after preincubation with granulocyte-macrophage colony-stimulating factor (GM-CSF), tumor necrosis factor, IL-3, IL-6, M-CSF, and IL-l.23,24 In support of contact-mediated interactions, Fuchshuber and L o t~o v a~~ recently showed that cultured tumor targets require direct cell-cell contact with bone marrow cells to expand the CD56+/CD3-NK population.
There were minor differences in ANK phenotype that were influenced by culture conditions and starting population. CD16 and CD7 are downregulated from bright expression to dim expression compared with the starting population. The significance of these phenotypic changes are currently undefined but may correlate with important target recognition or activation signal events. Approximately 30% of ANK coexpress CD8. These phenotype characteristics of cultured ANK were independent of culture conditions, rIL-2 concentration, the presence or absence of accessory cells, the initiation of culture with sorted cells, or cells obtained after CD5/CD8 depletion. This suggests de novo synthesis or upregulation of CD8 on ANK derived from CD56+/CD8-cells or the CDS/CDS-depleted starting population. Similar coexpression of CD8 on NK has recently been reported by Baume et a1.26 They report that the CD8 complex consists of a and p chains, CD56+/CD3-NK usually express only the CD8a chain, CD3+ T lymphocytes contain both CD8a and CDSp, and CD8a on NK has no obvious functional role in major histocompatibility complex unrestricted cytotoxicity.
All cultured ANK had potent cytotoxic activity against NK-sensitive and NK-resistant tumor targets. Cytotoxicity was independent of the presence or absence of accessory cells, the accessory population used, and was similar for sorted cells or negatively depleted starting populations. These data strongly suggest that rIL-2 alone is sufficient to induce NK cytolytic machinery, in contrast to NK proliferation that requires accessory cell factors in addition to rIL-2 for maximal expansion. Whether or not NK had direct contact with accessory cells, high rIL-2 concentrations were required for maximal NK-resistant killing but was less important for NK-sensitive killing. These data suggest that although proliferation of ANK can be achieved with low Finally, we developed a simplified method to enrich for a starting monocytes and NK population to culture large numbers of homogeneous CD56+/CD3-ANK. This negative depletion method uses CDS/CD8-coated flasks followed by optimal culture conditions and can b e easily adapted to large-scale production. These studies describe important proliferation and activation requirements that may lead to novel therapeutic strategies using ex vivo cultured ANK.
